Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study of the tolerance and acceptability of a extensively hydrolysed formula (eHF) containing pre- and probiotics will assess gastrointestinal (GI) tolerance, product intake and acceptability in 40 infants (aged <13 months) currently using or requiring an extensively hydrolysed formula for the dietary management of CMA. Patients already prescribed an eHF (or other appropriate feed for CMA) at time of recruitment will undertake a 3 day baseline period in which their current symptoms, compliance, GI tolerance and acceptability towards their current feed is assessed, before introducing the study product for a period of 4 weeks. Patients who are not on an eHF (or other appropriate feed for CMA) at baseline will forgo this 3 day baseline period and immediately introduce the study product for 4 weeks.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Study product | Experimental | Extensively Hydrolysed Formula containing Pre- and Probiotics |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Extensively Hydrolysed Formula containing Pre- & Probiotics | Dietary Supplement | Extensively Hydrolysed Formula containing Pre- and Probiotics |
|
| Measure | Description | Time Frame |
|---|---|---|
| Change in gastrointestinal tolerance from baseline to intervention day 28: questionnaire | Gastro-intestinal tolerance will be recorded by the parent on Baseline Days 1-3 (where this period is undertaken by the patient) and on Intervention Days 1, 2, 3, 7, 14, 21, 26, 27, and 28. Tolerance will be recorded using a standardised gastro-intestinal tolerance questionnaire, to be completed by the parents/carer | 31 days |
| Measure | Description | Time Frame |
|---|---|---|
| Compliance | Compliance with feed prescription will be assessed daily throughout the study by recording how much feed was received. The amount prescribed by the Dietitian will be recorded at the start of the study, and any changes to this prescription also noted. During the baseline period (where this is undertaken) the compliance of the patient's usual feed will be assessed. | 31 days |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Brighton and Sussex University Hospital NHS Foundation Trust | Brighton | United Kingdom | ||||
| University Hospitals Bristol NHS Foundation Trust |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D016269 | Milk Hypersensitivity |
| ID | Term |
|---|---|
| D005512 | Food Hypersensitivity |
| D006969 | Hypersensitivity, Immediate |
| D006967 | Hypersensitivity |
| D007154 | Immune System Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D019936 | Probiotics |
| ID | Term |
|---|---|
| D019587 | Dietary Supplements |
| D005502 | Food |
| D000066888 | Diet, Food, and Nutrition |
| D010829 | Physiological Phenomena |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Parent-reported Atopic Symptoms | Recorded via visual analogue scales at baseline and at the end of each week. Parents will record on a 100mm line the severity of a number of common atopic symtpoms, with the scale running from "not at all/none" at 0mm and "as bad as possible/ | 31 days |
| Food Allergy QOL - Parental burden questionnaire | Measured at baseline and at the end of study via a Food Allergy QOL - Parental Burden Questionnaire | 31 days |
| Formula acceptability: Likert-style questionnaire | Feed acceptability will be assessed on Baseline Day 3 (for current feed, where applicable) and on the final day of the intervention period (Intervention day 28) via a Likert-style questionnaire | 31 days |
| Nutrient intake | Nutrient intake, including the intake of all nutrition provided (including the study product, any other enteral tube feeding, foods, drinks etc.) will be recorded via a 24hr dietary recall, conducted by the Dietitian at the Baseline Visit and at the End of Study Visit. | 31 days |
| Atopic dermatitis severity | Measured via Patient Orientated SCORing Atopic Dermatitis (PO-SCORAD) tool at Baseline, Intervention Day 7 and the final dat of the study | 31 days |
| Change in weight | Weight will be measured at the start and end of the study in kg | 31 days |
| Safety (Adverse Events) | Adverse events captured throughout entire study | 31 days |
| Change in length (cm) | Length will be measured at the start and end of the study | 31 days |
| Change in head circumference (cm) | Head circumference will be measured at the start and end of the study | 31 days |
| Bristol |
| United Kingdom |
| Ashford and St Peter's Hospital NHS Foundation Trust | Chertsey | United Kingdom |
| Royal Surrey County Hospital NHS Foundation Trust | Guildford | United Kingdom |
| Guy's and St Thomas' NHS Foundation Trust | London | United Kingdom |
| The Rotherham NHS Foundation Trust | Rotherham | United Kingdom |
| university Hospitals Southampton NHS Foundation Trust | Southampton | United Kingdom |
| West Hertfordshire NHS Foundation Trust | Watford | United Kingdom |
| D019602 |
| Food and Beverages |